(RBC) RBC Bearings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US75524B1044
Stock: Bearings, Components, Gearing, Hydraulics, Fasteners
Total Rating 71
Risk 77
Buy Signal -0.28
| Risk 5d forecast | |
|---|---|
| Volatility | 25.4% |
| Relative Tail Risk | -12.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.86 |
| Alpha | 39.49 |
| Character TTM | |
|---|---|
| Beta | 1.016 |
| Beta Downside | 1.278 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.81% |
| CAGR/Max DD | 2.12 |
EPS (Earnings per Share)
Revenue
Description: RBC RBC Bearings March 04, 2026
RBC Bearings Incorporated designs and manufactures precision bearings, components, and systems. The company operates in two segments: Aerospace/Defense and Industrial. This dual focus allows participation in both highly specialized, regulated markets and broader industrial applications.
Product offerings include various plain, roller, and ball bearings, along with mounted bearings and enclosed gearing. The company also provides power transmission components, hydraulic systems, fasteners, and precision mechanical components. This extensive product range supports diverse industrial machinery and equipment.
RBC Bearings serves a wide array of sectors, including commercial and defense aerospace, construction, mining, energy, agriculture, and material handling. Distribution occurs through a direct sales force and a network of industrial and aerospace distributors. The industrial bearings market is characterized by a need for durable, high-performance components critical to machinery longevity.
For more detailed financial and operational data, ValueRay offers comprehensive analytics.
Headlines to watch out for
- Aerospace and defense spending drives demand for precision bearings
- Industrial machinery production impacts bearing sales
- Raw material cost fluctuations affect manufacturing margins
- Global economic conditions influence capital expenditure on equipment
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 268.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.87 > 1.0 |
| NWC/Revenue: 31.52% < 20% (prev 44.07%; Δ -12.55% < -1%) |
| CFO/TA 0.08 > 3% & CFO 399.7m > Net Income 268.6m |
| Net Debt (997.9m) to EBITDA (521.9m): 1.91 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.6m) vs 12m ago 1.35% < -2% |
| Gross Margin: 42.13% > 18% (prev 0.44%; Δ 4.17k% > 0.5%) |
| Asset Turnover: 36.52% > 50% (prev 34.56%; Δ 1.96% > 0%) |
| Interest Coverage Ratio: 7.78 > 6 (EBITDA TTM 521.9m / Interest Expense TTM 51.4m) |
Altman Z'' 3.24
| A: 0.11 (Total Current Assets 1.22b - Total Current Liabilities 656.4m) / Total Assets 5.14b |
| B: 0.32 (Retained Earnings 1.65b / Total Assets 5.14b) |
| C: 0.08 (EBIT TTM 399.7m / Avg Total Assets 4.90b) |
| D: 0.88 (Book Value of Equity 1.65b / Total Liabilities 1.88b) |
| Altman-Z'' Score: 3.24 = A |
Beneish M -2.95
| DSRI: 1.00 (Receivables 285.8m/256.1m, Revenue 1.79b/1.61b) |
| GMI: 1.05 (GM 42.13% / 44.10%) |
| AQI: 0.96 (AQ_t 0.67 / AQ_t-1 0.70) |
| SGI: 1.11 (Revenue 1.79b / 1.61b) |
| TATA: -0.03 (NI 268.6m - CFO 399.7m) / TA 5.14b) |
| Beneish M-Score: -2.95 (Cap -4..+1) = A |
What is the price of RBC shares?
As of March 13, 2026, the stock is trading at USD 559.52 with a total of 148,676 shares traded.
Over the past week, the price has changed by -3.31%, over one month by -0.56%, over three months by +18.94% and over the past year by +62.39%.
Over the past week, the price has changed by -3.31%, over one month by -0.56%, over three months by +18.94% and over the past year by +62.39%.
Is RBC a buy, sell or hold?
RBC Bearings has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy RBC.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RBC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 608.7 | 8.8% |
| Analysts Target Price | 608.7 | 8.8% |
RBC Fundamental Data Overview March 13, 2026
P/E Trailing = 64.6678
P/E Forward = 29.7619
P/S = 9.7635
P/B = 5.5274
P/EG = 1.396
Revenue TTM = 1.79b USD
EBIT TTM = 399.7m USD
EBITDA TTM = 521.9m USD
Long Term Debt = 701.6m USD (from longTermDebt, last quarter)
Short Term Debt = 304.1m USD (from shortTermDebt, last quarter)
Debt = 1.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 997.9m USD (from netDebt column, last quarter)
Enterprise Value = 18.48b USD (17.48b + Debt 1.11b - CCE 107.6m)
Interest Coverage Ratio = 7.78 (Ebit TTM 399.7m / Interest Expense TTM 51.4m)
EV/FCF = 55.98x (Enterprise Value 18.48b / FCF TTM 330.1m)
FCF Yield = 1.79% (FCF TTM 330.1m / Enterprise Value 18.48b)
FCF Margin = 18.44% (FCF TTM 330.1m / Revenue TTM 1.79b)
Net Margin = 15.00% (Net Income TTM 268.6m / Revenue TTM 1.79b)
Gross Margin = 42.13% ((Revenue TTM 1.79b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 39.73% (prev 44.06%)
Tobins Q-Ratio = 3.59 (Enterprise Value 18.48b / Total Assets 5.14b)
Interest Expense / Debt = 1.18% (Interest Expense 13.0m / Debt 1.11b)
Taxrate = 24.52% (21.9m / 89.3m)
NOPAT = 301.7m (EBIT 399.7m * (1 - 24.52%))
Current Ratio = 1.86 (Total Current Assets 1.22b / Total Current Liabilities 656.4m)
Debt / Equity = 0.34 (Debt 1.11b / totalStockholderEquity, last quarter 3.26b)
Debt / EBITDA = 1.91 (Net Debt 997.9m / EBITDA 521.9m)
Debt / FCF = 3.02 (Net Debt 997.9m / FCF TTM 330.1m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.48% (Net Income 268.6m / Total Assets 5.14b)
RoE = 8.53% (Net Income TTM 268.6m / Total Stockholder Equity 3.15b)
RoCE = 10.38% (EBIT 399.7m / Capital Employed (Equity 3.15b + L.T.Debt 701.6m))
RoIC = 7.32% (NOPAT 301.7m / Invested Capital 4.12b)
WACC = 9.14% (E(17.48b)/V(18.59b) * Re(9.66%) + D(1.11b)/V(18.59b) * Rd(1.18%) * (1-Tc(0.25)))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.09%
[DCF] Terminal Value 77.05% ; FCFF base≈301.6m ; Y1≈358.2m ; Y5≈558.9m
[DCF] Fair Price = 212.8 (EV 7.73b - Net Debt 997.9m = Equity 6.73b / Shares 31.6m; r=9.14% [WACC]; 5y FCF grow 20.01% → 2.90% )
EPS Correlation: 74.78 | EPS CAGR: 26.47% | SUE: 1.74 | # QB: 5
Revenue Correlation: 91.71 | Revenue CAGR: 6.94% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.37 | Chg7d=+0.000 | Chg30d=+0.069 | Revisions Net=+3 | Analysts=5
EPS next Year (2027-03-31): EPS=13.95 | Chg7d=+0.020 | Chg30d=+0.445 | Revisions Net=+8 | Growth EPS=+14.6% | Growth Revenue=+12.1%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.1% (Discount Rate 9.7% - Earnings Yield 1.5%)
[Growth] Growth Spread = +6.1% (Analyst 14.2% - Implied 8.1%)
P/E Forward = 29.7619
P/S = 9.7635
P/B = 5.5274
P/EG = 1.396
Revenue TTM = 1.79b USD
EBIT TTM = 399.7m USD
EBITDA TTM = 521.9m USD
Long Term Debt = 701.6m USD (from longTermDebt, last quarter)
Short Term Debt = 304.1m USD (from shortTermDebt, last quarter)
Debt = 1.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 997.9m USD (from netDebt column, last quarter)
Enterprise Value = 18.48b USD (17.48b + Debt 1.11b - CCE 107.6m)
Interest Coverage Ratio = 7.78 (Ebit TTM 399.7m / Interest Expense TTM 51.4m)
EV/FCF = 55.98x (Enterprise Value 18.48b / FCF TTM 330.1m)
FCF Yield = 1.79% (FCF TTM 330.1m / Enterprise Value 18.48b)
FCF Margin = 18.44% (FCF TTM 330.1m / Revenue TTM 1.79b)
Net Margin = 15.00% (Net Income TTM 268.6m / Revenue TTM 1.79b)
Gross Margin = 42.13% ((Revenue TTM 1.79b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 39.73% (prev 44.06%)
Tobins Q-Ratio = 3.59 (Enterprise Value 18.48b / Total Assets 5.14b)
Interest Expense / Debt = 1.18% (Interest Expense 13.0m / Debt 1.11b)
Taxrate = 24.52% (21.9m / 89.3m)
NOPAT = 301.7m (EBIT 399.7m * (1 - 24.52%))
Current Ratio = 1.86 (Total Current Assets 1.22b / Total Current Liabilities 656.4m)
Debt / Equity = 0.34 (Debt 1.11b / totalStockholderEquity, last quarter 3.26b)
Debt / EBITDA = 1.91 (Net Debt 997.9m / EBITDA 521.9m)
Debt / FCF = 3.02 (Net Debt 997.9m / FCF TTM 330.1m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.48% (Net Income 268.6m / Total Assets 5.14b)
RoE = 8.53% (Net Income TTM 268.6m / Total Stockholder Equity 3.15b)
RoCE = 10.38% (EBIT 399.7m / Capital Employed (Equity 3.15b + L.T.Debt 701.6m))
RoIC = 7.32% (NOPAT 301.7m / Invested Capital 4.12b)
WACC = 9.14% (E(17.48b)/V(18.59b) * Re(9.66%) + D(1.11b)/V(18.59b) * Rd(1.18%) * (1-Tc(0.25)))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.09%
[DCF] Terminal Value 77.05% ; FCFF base≈301.6m ; Y1≈358.2m ; Y5≈558.9m
[DCF] Fair Price = 212.8 (EV 7.73b - Net Debt 997.9m = Equity 6.73b / Shares 31.6m; r=9.14% [WACC]; 5y FCF grow 20.01% → 2.90% )
EPS Correlation: 74.78 | EPS CAGR: 26.47% | SUE: 1.74 | # QB: 5
Revenue Correlation: 91.71 | Revenue CAGR: 6.94% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.37 | Chg7d=+0.000 | Chg30d=+0.069 | Revisions Net=+3 | Analysts=5
EPS next Year (2027-03-31): EPS=13.95 | Chg7d=+0.020 | Chg30d=+0.445 | Revisions Net=+8 | Growth EPS=+14.6% | Growth Revenue=+12.1%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.1% (Discount Rate 9.7% - Earnings Yield 1.5%)
[Growth] Growth Spread = +6.1% (Analyst 14.2% - Implied 8.1%)